Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea | Scientific ...

2024-09-22 04:44:54 | valent vaccine

You are leaving and open the following URL" of about "valent vaccine" news

news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3Lm5hdHVyZS5jb20vYXJ0aWNsZXMvczQxNTk4LTAyMi0yMDM2My050gEA?oc=5

valent vaccine: Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea | Scientific ...

More valent vaccine news:

2024-03-14 07:00 머크, “더 범위 넓힌” 다가 HPV백신 “4Q 임상개시” - 바이오스펙테이터
2024-06-24 07:00 [Korea’s Blockbuster Vaccine] SK Bioscience ‘Pneumococcus' Vaccine Enters Global Phase 3 - 위키리크스한국
2024-03-05 08:00 Korea to launch MSD's 15-valent PCV vaccine in national immunization program - KBR
2023-12-11 08:00 SK Bioscience and Sanofi Advance Clinical Trials for Innovative Pneumococcal Vaccine - Korea IT Times
2023-04-07 07:00 Cooperation Agreement Concluded between BioKangtai and Biotis - 팜뉴스
2024-06-25 07:00 SK bioscience, Sanofi win Australian nod for phase 3 study of 21-valent pneumococcal vaccine - KBR
2018-06-11 07:00 [이엠디] 프리베나®13주, 65세 이상 성인 대상 리얼월드 유효성 확인 - 이엠디
2019-07-03 07:00 최윤홍 (Public Health England) - 생물학연구정보센터(BRIC)
2019-08-20 07:00 POSVAX Challenges Development of '9-valent HPV Vaccine' with VLP Platform - 바이오스펙테이터

2022-11-21 08:00 Jiangsu Recbio Technology Co., Ltd. Increases Production For The First Phase Of Manufacturing Facility With A Maximum Annual Output Of 20 Million Doses Of Recombinant HPV 9-Valent Vaccine - 팜뉴스
2020-01-20 08:00 [이엠디] 화이자제약, ‘일삼이와 함께하는 하이파이브’ 기부캠페인 개최 - 이엠디
2023-12-11 08:00 SK bioscience, Sanofi seek FDA nod for phase 3 study of 21-valent pneumococcal conjugate vaccine - KBR
2022-11-21 08:00 Immorna Receives IND Clearance to Conduct a Phase 1/2 Study of JCXH-221, a Broadly Protective mRNA-Based COVID-19 Vaccine - 팜뉴스
2017-04-25 07:00 [이엠디] 프리베나13, NIP 도입한 주요 국가의 질환 감소 임팩트 데이터 공개 - 이엠디
2018-10-08 07:00 가다실9, 접종 연령 상한선 45세로 확대 - 팜뉴스
2017-02-20 08:00 프리베나13, 임팩트 캠페인 진행 - 이엠디
2020-05-26 07:00 ‘신플로릭스’, 국내 영유아에서 13가 폐렴구균 백신 대비 급성중이염 재발 4.6배 더 효과적으로 예방 - 이엠디
2019-04-06 07:00 [이엠디] 화이자 ‘2019 프리베나®13 백신클래스’ 개최 - 이엠디
2016-05-03 07:00 [이엠디] GSK ‘신플로릭스’ 국내 허가사항에 19A혈청형 데이터 추가 - 이엠디

2016-07-25 07:00 [이엠디] 한국MSD, 9가 자궁경부암 백신 ‘가다실®9’ 출시 - 이엠디
2023-09-22 07:00 2Q 톱10 베스트셀링 약품…코로나 아웃, HPV 진입 - 메디팜스투데이
2017-12-26 08:00 [이엠디] 지적인 이미지의 이보영, GSK 폐렴구균 백신 ‘신플로릭스’, 광고모델로 발탁 - 이엠디
2016-04-29 07:00 [이엠디] 한국화이자제약, ‘프리베나13 - H.E.R.O 심포지엄’ 성료 - 이엠디
2017-01-31 08:00 [이엠디] 자궁경부암 백신 ‘가다실®9’ 2회 접종 승인 - 이엠디
2021-06-09 07:00 화이자, 폐렴구균 20가 결합백신 승인 - 메디팜스투데이
2024-07-30 07:00 National immunization rate for children reaches 96% at age 1 - KBR

About valent vaccine

2024-09-22 from kr

Warning: file_get_contents(aCache/search/kr/valent vaccine): Failed to open stream: Permission denied in /var/www/hoodb/function.php on line 340

valent vaccine, Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea | Scientific ... 2022 valent vaccine

Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea | Scientific ...

Choose Your Country or Region

Back to Top

Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea | Scientific ...